Enabling next generation medicines
A comprehensive platform and product suite for
Advanced therapeutics
Designing scalable
therapeutic systems
The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up.
Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out.
Gene Therapies
AAV Apex Suite delivers high yield cell lines and production technologies built for AAV at scale — independently confirmed by leading biopharmas and CDMOs across serotypes, payloads, and scales.
Cell Therapies
VectorSelect optimizes production cell lines for lentivirus manufacturing.
Biologics
VectorSelect optimizes production cell lines for a wide range of biologics.
Change the math for next generation medicines with VectorSelecT and aav apex suite
01
License our high performance cell lines through AAV Apex Suite
02
flexible cell line optimization with VectorSelect
03
Enhanced cell lines for other biologics through VectorSelect
Experts in scalable bioengineering
64x is on a mission to unlock the potential of next generation therapies by reengineering how they’re made.